Skip to content

Abcuro, Inc vs Smart Immune

Abcuro, Inc logo

Abcuro, Inc

Developing immunotherapies for autoimmune diseases and cancer

43 employees · est. 2015

VS
Smart Immune logo

Smart Immune

Pioneering thymus-empowered T-cell platform to fight cancer and infection

35 employees · est. 2017 · Paris, France

Abcuro, Inc is the older company (2015 vs 2017).

Side-by-Side Comparison

Abcuro, Inc Smart Immune
Founded
2015 older 2017
Headquarters
Not tracked yet Paris, France
Employees
43 35
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Health Care, Health and Wellness
Funding Stage
Series B Grant
Total Funding
$214.85M $25.30M
Funding Rounds
5 5
Taxonomy
ImmunotherapyAutoimmune DiseasesCancer TreatmentsClinical StageAnti-KLRG1 AntibodyOrphan Drug Designation +8 Cell TherapyCAR TImmuno-oncologyNK CellsT CellsImmune Reconstitution +8
Website
abcuro.com smart-immune.com
Abcuro, Inc logo

About Abcuro, Inc

Abcuro, Inc is a clinical stage biotechnology company founded in 2015 that focuses on developing immunotherapies for autoimmune diseases and cancer. The company is known for its flagship products ABC008 and ABC015, both of which target cytotoxic T and NK cells expressing the inhibitory immune checkp...

Smart Immune logo

About Smart Immune

Smart Immune is a French biotechnology startup with a mission to revolutionize treatment outcomes for cancer and infectious diseases. Founded in 2017, the company is focused on developing ProTcell, a groundbreaking thymus-empowered T cell progenitor platform. This innovative technology aims to rapid...

Also comparing in this category

Comparing more than these two?

Get Abcuro, Inc, Smart Immune and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Abcuro, Inc compare?

A PDF of Abcuro, Inc and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Abcuro, Inc was founded in 2015, with 43 employees. Abcuro, Inc is a clinical stage biotechnology company founded in 2015 that focuses on developing immunotherapies for autoimmune diseases and cancer. The company is known for its flagship products ABC0. Smart Immune was founded in 2017, based in Paris, France, with 35 employees. Smart Immune is a French biotechnology startup with a mission to revolutionize treatment outcomes for cancer and infectious diseases. Founded in 2017, the company is focused on developing ProTcell, a.
Abcuro, Inc has raised $214.85M and Smart Immune $25.30M. Latest stage: Abcuro, Inc Series B, Smart Immune Grant.
Both work in Biotechnology, Health Care and Health and Wellness and list nk cells among their focus areas.

Compare Abcuro, Inc with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Abcuro, Inc on 11 Sep 2024, and Smart Immune on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout